National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 478 cases where Vaccine targets Measles (MEA or MER or MM or MMR or MMRV) and Patient Died and Vaccination Date on/before '2018-11-30'

Case Details

This is page 25 out of 48

Result pages: prev   16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34   next


VAERS ID: 573401 (history)  
Form: Version 1.0  
Age: 15.0  
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-04-10
Entered: 2015-04-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTP: DTP (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 4 UN / UN
HIBV: HIB (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 1 UN / UN
MMR: MEASLES + MUMPS + RUBELLA (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 2 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Acute respiratory distress syndrome, Aspiration bone marrow normal, Blood culture negative, Chest X-ray normal, Computerised tomogram normal, Death, Dyspnoea, Electroencephalogram normal, Enterobacter infection, Face oedema, Hypotension, Iatrogenic infection, Leukopenia, Lung consolidation, Mechanical ventilation, Multi-organ failure, Pancytopenia, Petechiae, Platelet count decreased, Pneumonia, Pyrexia, Respiratory tract infection, Septic shock, Stenotrophomonas sepsis, Stenotrophomonas test positive, Thrombocytopenia, Urinary tract infection pseudomonal, Varicella, Varicella virus test positive, White blood cell count decreased
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Agranulocytosis (narrow), Angioedema (narrow), Haematopoietic cytopenias affecting more than one type of blood cell (narrow), Haematopoietic leukopenia (narrow), Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Interstitial lung disease (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (narrow), Anticholinergic syndrome (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (narrow), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypersensitivity (narrow), Myelodysplastic syndrome (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (narrow), Infective pneumonia (narrow), Dehydration (broad), Hypokalaemia (broad), Sepsis (narrow), Opportunistic infections (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 21 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Aspiration bone marrow, no evidence of leukaemia absent; Blood culture, Positive for Stenotrophomonas maltophilia absent; Blood culture, Negative absent; Body temperature, 101.1 degree F; Chest X-ray, Alveolar consolidation absent; Computerised tomogram, no intracranial lesions absent; Electroencephalogram, excluded subclinical seizures absent
CDC Split Type: US2015GSK047296

Write-up: This case was reported in a literature article and described the occurrence of varicella in a 15-year-old female subject who received DTP (A or W not known) vaccine. Previously administered products included DTP (A or W unknown) vaccine with an associated reaction of no adverse event (1st dose), DTP (A or W not known) vaccine with an associated reaction of no adverse event (2nd dose), DTP (A or W not known) vaccine with an associated reaction of no adverse event (3rd dose) and MMR vaccine with an associated reaction of no adverse event (2nd dose). Concomitant products included MMR vaccine. On an unknown date, an unknown time after receiving DTP (A or W not known) vaccine and Hib vaccine, the subject developed severe - grade 3 varicella. Serious criteria included death and hospitalization. Additional event(s) included fever, shortness of breath, face edema, petechial rash, hypotension, pneumonia with serious criteria of GSK medically significant, acute respiratory distress syndrome with serious criteria of GSK medically significant, pancytopenia with serious criteria of GSK medically significant, multi-organ failure with serious criteria of GSK medically significant, iatrogenic infection, enterobacter cloacae infection with serious criteria of GSK medically significant, respiratory tract infection with serious criteria of GSK medically significant, urinary tract infection pseudomonal with serious criteria of GSK medically significant, Stenotrophomonas sepsis with serious criteria of GSK medically significant, thrombocytopenia, leukopenia with serious criteria of GSK medically significant and lung consolidation. The subject was treated with acyclovir, antibiotics unknown, antifungals for systemic use, ciprofloxacin, meropenem, Sulfamethoxazole + Trimethoprim, Ticarcillin + Clavulanate and tigecycline. The outcome of varicella was fatal. The outcome(s) of the additional event(s) included fever (unknown), shortness of breath (unknown), face edema (unknown), petechial rash (unknown), hypotension (unknown), pneumonia (unknown), acute respiratory distress syndrome (unknown), pancytopenia (unknown), multi-organ failure (unknown), iatrogenic infection (unknown), enterobacter cloacae infection (unknown), respiratory tract infection (unknown), urinary tract infection pseudomonal (unknown), Stenotrophomonas sepsis (unknown), thrombocytopenia (unknown), leukopenia (unknown) and lung consolidation (unknown). The reported cause of death was varicella. It was unknown if the investigator considered the varicella, fever, shortness of breath, face edema, petechial rash, hypotension, pneumonia, acute respiratory distress syndrome, pancytopenia, multi-organ failure, iatrogenic infection, enterobacter cloacae infection, respiratory tract infection, urinary tract infection pseudomonal, Stenotrophomonas sepsis, thrombocytopenia, leukopenia and lung consolidation to be related to DTP (A or W not known) vaccine and Hib vaccine. Diagnostic results (unless otherwise stated, normal values were not provided): On 14th March 2009, Varicella virus test result was Positive absent. On an unknown date, Aspiration bone marrow result was no evidence of leukaemia absent. On an unknown date, Blood culture result was Negative absent. On an unknown date, Blood culture result was Positive for Stenotrophomonas maltophilia absent. On an unknown date, Body temperature result was 101.1 degree F. On an unknown date, Chest X-ray result was Alveolar consolidation absent. On an unknown date, Computerised tomogram result was no intracranial lesions absent. On an unknown date, Electroencephalogram result was excluded subclinical seizures absent. On an unknown date, Platelet count result was 30,000 /mcL. On an unknown date, White blood cell count result was 1,400 /mcL. Additional information received: This case was reported in a literature article and it described the occurrence of a varicella infection in a 15-year-old female patient who had been vaccinated with unspecified DTP vaccines, unspecified Hib vaccine and unspecified MMR vaccines (manufacturers unknown). The patient had been healthy prior to the event and had no known underlying medical conditions according to the authors. She lived in a community with low rates of varicella vaccination and the source individual was never identified. No further information on the patient''s medical or family history, concurrent medical conditions or concomitant medication was provided. On an unspecified dates, the patient received 4 doses of an unspecified DTP vaccine, 1 dose of an unspecified Hib vaccine and 2 doses of an unspecified MMR (administration routes and sites unspecified; dosages unknown, batch numbers not provided). Please note that the authors commented that she had not been vaccinated against varicella. On 12 March 2009, an unknown period after the vaccinations she was admitted to hospital with a 3-day history of a rash consistent with varicella and a 1-day history of fever and shortness of breath. Upon examination on admission, she was noted to be awake and alert, febrile (101.1 deg. F) dyspnoeic, had facial oedema, generalized petechial rash and hypotension; so she was diagnosed with septic shock. She was initially placed on non-invasive mechanical ventilation, but her respiratory function continued to deteriorate and she required invasive mechanical ventilation after 6 hours. In addition to this, she later developed pneumonia complicated by acute respiratory distress syndrome, pancytopenia, multi-organ dysfunction, iatrogenic colonization and infection (respiratory tract colonization with Enterobacter cloacae and urinary tract infection with Pseudomonas aeruginosa) and sepsis. Further deterioration of her respiratory function require progressively higher levels of oxygen and pressure during her last week in hospital. She died on day 21 of admission. Varicella was recorded as the underlying cause of death, and this was validated by an investigation performed by the state Department of Health. The authors did not mention if a post-mortem had been performed. Laboratory tests performed on admission revealed thrombocytopenia (platelet count: 30,000/mcL) and leucopoenia (white blood cell count: 1,400/mcL). Blood cultures taken on admission were negative, but direct fluorescent antibody test performed on a sample of vesicular fluid collected on 14 March 2009 was positive for varicella-zoster virus. Blood cultures taken on hospital days 19 and 20 were positive for Stenotrophomonas maltophilia. Further blood cultures collected while she was on antibiotics were negative. In addition to this the authors commented that she had been diagnosed with Enterobacter cloacae respiratory tract colonization and Pseudomonas aeruginosa urinary tract infection, but the details of those tests were not provided. She underwent multiple chest X-Rays that showed diffuse, tiny nodules in the lung parenchyma consistent with alveolar consolidation. Computed tomography scan did not identify any intracranial lesions and electroencephalography excluded any subclinical seizures. Bone marrow aspirate obtained during her hospitalisation showed no evidence of leukaemia according to the authors. Initial treatment consisted of intravenous acyclovir (started on day 4 of illness) and broad-spectrum antibiotics and antifungals, in addition to respiratory support. She was later commenced on ciprofloxacin, meropenem, trimethoprim-sulfamethoxazole, ticarcillin-clavulanate and tigecycline. The outcome of the event was death. The authors did not comment on any causal relationship between the vaccines the patient received and this event. The authors concluded that "Severe varicella can develop among unvaccinated healthy persons, and which patients might develop an especially severe course often is unpredictable. Persons without evidence of immunity to varicella should received 2 doses of varicella vaccine or a second dose if they have received only 1 dose, to prevent varicella and its severe complications."


VAERS ID: 577000 (history)  
Form: Version 1.0  
Age: 0.3  
Sex: Male  
Location: Indiana  
Vaccinated:2005-03-09
Onset:2005-03-10
   Days after vaccination:1
Submitted: 2015-05-06
   Days after onset:3708
Entered: 2015-05-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / -
HEPAB: HEP A + HEP B (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / -
MMR: MEASLES + MUMPS + RUBELLA (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / -

Administered by: Unknown       Purchased by: Private
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2005-03-10
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: No.
Preexisting Conditions: No
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Death.


VAERS ID: 580878 (history)  
Form: Version 1.0  
Age: 0.24  
Sex: Female  
Location: California  
Vaccinated:1990-05-19
Onset:1990-05-19
   Days after vaccination:0
Submitted: 2015-06-08
   Days after onset:9151
Entered: 2015-06-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTPHEP: DTP + HEP B (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 2 UN / -
MMR: MEASLES + MUMPS + RUBELLA (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 2 UN / -
OPV: POLIO VIRUS, ORAL (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 2 UN / -
UNK: VACCINE NOT SPECIFIED (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 2 UN / -

Administered by: Private       Purchased by: Other
Symptoms: Cold sweat, Crying, Death, Decreased appetite, Laboratory test, Lethargy, Pallor
SMQs:, Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Depression (excl suicide and self injury) (broad), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 1990-05-21
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Patient was on nothing else...
Current Illness: Patient had been mildly ill about a month prior to her vaccinations. She was healthy for several weeks prior to vaccination.
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: Too dang many to list you are welcome to get her records
CDC Split Type:

Write-up: My daughter got her vaccines and within hours was lethargic, no appetite, clammy to the touch, whimpering and pale.


VAERS ID: 590214 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-08-17
Entered: 2015-08-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Prophylaxis
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1508USA005868

Write-up: This spontaneous report was received from a physician via company representative regarding 100 unspecified patients. The physician reported an adverse event involving an unspecified measles vaccine. The physician stated that he had read an unspecified article in a locally published newsletter (name of the newsletter not provided). The article stated that there were hundred deaths caused by Measles, Mumps, and Rubella Virus Vaccine, (manufacturer unknown) (dose, strength, dose number, Lot no, vaccination site not specified). Concurrent conditions, medical history and concomitant medications were not provided. No further information was provided. The cause of death was not reported. Product quality complaint (PQC) was not reported. Additional information has been requested.


VAERS ID: 592715 (history)  
Form: Version 1.0  
Age: 1.75  
Sex: Female  
Location: Alabama  
Vaccinated:2015-08-31
Onset:2015-09-01
   Days after vaccination:1
Submitted: 2015-09-03
   Days after onset:2
Entered: 2015-09-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (PENTACEL) / SANOFI PASTEUR C4679AA / 1 LL / IM
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS 9CJ5Y / 1 LL / IM
MMRV: MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) / MERCK & CO. INC. K022448 / 1 RL / SC
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH L60102 / 3 RL / UN

Administered by: Private       Purchased by: Public
Symptoms: Blood pH decreased, Cardiac arrest, Drug screen negative, Life support, Retching, Urine ketone body present, pH urine normal
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Lactic acidosis (broad), Hyperglycaemia/new onset diabetes mellitus (narrow), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2015-09-01
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: No illness
Preexisting Conditions: Umbilicus hernia since birth
Allergies:
Diagnostic Lab Data: Urine drug screen negative; Urinalysis-ph5, ketones 15, blood ph 6.7
CDC Split Type:

Write-up: Dr received phone call from ER at 9:46 am. Dr at ER states child presented to the ER via personal automobile. Mom states patient was gagging all night. Child was in cardiac arrest when she arrived in the ER at 8:16 am. Pediatric advanced life support protocol active for one hour using every cardiac drug per Dr.


VAERS ID: 597662 (history)  
Form: Version 1.0  
Age: 4.0  
Sex: Female  
Location: Florida  
Vaccinated:2015-08-20
Onset:2015-08-22
   Days after vaccination:2
Submitted: 2015-09-28
   Days after onset:37
Entered: 2015-09-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 1000459 / 2 RA / SC
VARCEL: VARICELLA (NO BRAND NAME) / UNKNOWN MANUFACTURER 1015049 / 2 LA / SC

Administered by: Unknown       Purchased by: Public
Symptoms: Activities of daily living impaired, Bronchitis, Chest X-ray abnormal, Cough, Ecchymosis, Erythema, Full blood count normal, Haemoglobin decreased, Injection site pain, Mumps, Pyrexia, Respiratory arrest, Respiratory symptom, Resuscitation, Swelling face
SMQs:, Anaphylactic reaction (narrow), Angioedema (narrow), Haematopoietic erythropenia (broad), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Oropharyngeal infections (narrow), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Extravasation events (injections, infusions and implants) (broad), Cardiomyopathy (broad), Hypersensitivity (narrow), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2015-08-30
   Days after onset: 8
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Immodium, Flagyl, Calcium
Current Illness: None
Preexisting Conditions: History of short gut syndrome and SVC syndrome
Allergies:
Diagnostic Lab Data: CBC, = pediatricians office; chest xray- ER
CDC Split Type:

Write-up: Received 2 injections MMR and varicella. 1 injected in each arm. I questioned why in arm as patient''s extremities were very thin. Nurse said it was ok due to little needle and given SQ. 2 days later patient started with lowgrade fever and upper respiratory symptoms. Coughing. She missed school Mon & Tuesday. On Wed she went to her reg GI Dr. She had 103 fever and still coughing. Recommended back to ped. Returned to ped on Fri. Her reg Dr wasn''t in. They did a CBC which was ok but low Hgb which is her norm. O2 sat was ranging from 80 - 92. They were unsure if it worked. Dr recommended going to ER. Took her to ER. She had only 1 other complaint of rt arm hurt. They did chest xray and diagnosed bronchitis. Sent home on Zithromax, prednisone & breathing treatment. Sunday morning she woke up with left cheek swollen like mumps and a red ecchymotic area under her arm by chest. While getting her ready to go to hospital she took last breath. CPR started immediately and 911 called. Breaths did not seem to be going in. EMT took over CPR. Taken to hospital where they did get a heartbeat for less than a minute.


VAERS ID: 603163 (history)  
Form: Version 1.0  
Age: 1.03  
Sex: Male  
Location: Georgia  
Vaccinated:2015-10-05
Onset:2015-10-05
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2015-10-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. L001626 / 4 LL / UN
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS AD9Y4 / 1 LL / UN
HIBV: HIB (PEDVAXHIB) / MERCK & CO. INC. K025005 / 3 LL / UN
MMRV: MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) / MERCK & CO. INC. L023111 / 1 RL / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH L36483 / 4 RL / UN

Administered by: Private       Purchased by: Unknown
Symptoms: Interstitial lung disease, Laboratory test normal, Pyrexia, Sudden death, Toxicologic test normal, Viral myocarditis
SMQs:, Torsade de pointes/QT prolongation (broad), Interstitial lung disease (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2015-10-08
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Eczema; Allergic rhinitis
Preexisting Conditions: Eczema; Allergic rhinitis
Allergies:
Diagnostic Lab Data: Coroner''s report that toxicology and all other labs were negative. No bacterial infec and no allergic reaction.
CDC Split Type:

Write-up: Pt. received physical and shots on 10/5/15 and passed 10/8/15. Per family he had a fever x2d, no fever on 3rd day or 4th day and then died suddenly on 10/8/15. The coroner''s preliminary slides show viral myocarditis and interstitial pneumonia.


VAERS ID: 604092 (history)  
Form: Version 1.0  
Age: 2.0  
Sex: Male  
Location: Georgia  
Vaccinated:2015-10-19
Onset:2015-10-19
   Days after vaccination:0
Submitted: 2015-10-22
   Days after onset:3
Entered: 2015-10-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUX: INFLUENZA (SEASONAL) (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK UN / UN
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. - / UNK UN / SC
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Cardiac arrest, Death, Resuscitation
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Cardiomyopathy (broad), Respiratory failure (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2015-10-19
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Prophylaxis
Preexisting Conditions: Cardiac operation; Heart disease congenital
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1510USA009311

Write-up: This spontaneous report as received from a physician via a company representative refers to an approximately 2.5 year old male patient. The patient''s medical history included "hyperplastic left heart" and multiple unspecified heart surgeries. There was no information about the patient''s concurrent conditions or concomitant therapies provided. On 19-OCT-2015, at 12:30, the patient was vaccinated with a dose of M-M-R II, subcutaneously (lot # and expiration date were not reported), a dose of VARIVAX (Merck) (route of administration, lot # and expiration date were not reported) and a dose of an unspecified flu vaccine. On 19-OCT-2015, at 12:50, the patient was brought back to the provider''s office, apparently in cardiac arrest. The reporter stated they began performing cardiopulmonary resuscitation (CPR) on the patient and called for an ambulance. The ambulance took the patient to an emergency room. The reporter stated they received a call from the coroner''s office at 15:00, and was informed that the child died (on 19-OCT-2015). The event of cardiac arrest was reported as life threatening. The outcome of cardiac arrest was reported as fatal, however the cause of death was not provided. The relatedness between the adverse event and suspect therapies was not reported. Upon internal review, the event of cardiac arrest was considered to be medically significant. Additional information has been requested.


VAERS ID: 610282 (history)  
Form: Version 1.0  
Age: 1.1  
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-11-17
Entered: 2015-11-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. - / 1 UN / UN
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. - / 1 UN / UN
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Autoimmune haemolytic anaemia, Autopsy, Biopsy skin abnormal, Blood test abnormal, Coombs direct test positive, Coombs positive haemolytic anaemia, Cough, Death, Depressed level of consciousness, Diarrhoea, Disseminated intravascular coagulation, Eschar, General physical health deterioration, Hepatic failure, Herpes virus infection, Immune thrombocytopenic purpura, Immunoglobulin therapy, Immunohistochemistry, Jaundice, Leukocytosis, Lymphoblast count, Lymphocyte count decreased, Lymphopenia, Ophthalmic herpes zoster, Ophthalmological examination abnormal, Platelet count decreased, Polymerase chain reaction positive, Pyrexia, Rash, Rash papular, Renal failure, Rhinorrhoea, Rotavirus test negative, Rubivirus test positive, Rubulavirus test positive, Skin lesion, Transfusion, Varicella virus test positive, Varicella zoster virus infection, Viral test negative, White blood cell count increased
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Cholestasis and jaundice of hepatic origin (narrow), Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow), Haemolytic disorders (narrow), Anaphylactic reaction (narrow), Acute pancreatitis (broad), Haematopoietic leukopenia (narrow), Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (narrow), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Pseudomembranous colitis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Malignancy related therapeutic and diagnostic procedures (narrow), Biliary system related investigations, signs and symptoms (narrow), Biliary tract disorders (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Optic nerve disorders (broad), Corneal disorders (broad), Ocular infections (narrow), Skin tumours of unspecified malignancy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Chronic kidney disease (narrow), Hypersensitivity (narrow), Noninfectious diarrhoea (narrow), Tumour lysis syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (narrow), Hypoglycaemia (broad), Opportunistic infections (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Methylprednisolone sodium succinate
Current Illness: Gene mutation
Preexisting Conditions: Rotavirus vaccine (unspecified), drug tolerance
Allergies:
Diagnostic Lab Data: Immune thrombocytopenic purpura (date unknown): nadir 25,000 platelets/microliter. Varicella zoster virus (VZV) was detected in her cerebrospinal fluid (723 copies/mL), skin (137,156 copies/mL) and esophagus by PCR assays and immunohistochemistry. Stool samples submitted for viral electron microscopy were negative, including assessment for rotavirus. Lymphoblast count (date unknown): lymphopenic. White blood cell count (date unknown): leukocytosis. Biopsy skin, intranuclear inclusion bodies typical of Herpesvi; Blood test, autoimmune hemolytic anemia; Ophthalmological examination, corneal dendrites with features of VZV infection; Polymerase chain reaction, mumps and rubella
CDC Split Type: WAES1511USA007746

Write-up: Information has been received from the authors in a literature article concerning a patient with VARIVAX (Merck) (manufacturer unknown), M-M-R II and methylprednisolone (manufacturer unknown) therapy. At 13 months of age, a previous healthy girl with RAG2 deficiency presented acutely with fever, jaundice, cough, rhinorrhea, diarrhea and approximately 10 erythematous papules on her torso and extremities. Preliminary studies revealed direct Coombs positive anemia and leukocytosis with granulocytes predominating. Initial treatment measures included blood transfusions, intravenous immunoglobulin (MG) and high dose methylprednisolone (manufacturer unknown) (up to 80 mg/day), leading to transient resolution of hemolysis. In addition, she developed autoimmune thrombocytopenia (nadir 25,000 platelets/1/4.L). Three weeks after onset of illness, her rash evolved into discrete 3-mm eschars; however, very few, if any new skin lesions developed. Skin biopsy revealed intranuclear inclusion bodies typical of Herpesviridae and intravenous acyclovir was initiated. Despite antiviral therapy, which later included foscarnet, her clinical status deteriorated over subsequent weeks. Obtundation ensued, and the patient died due to complications of hepatic and renal failure, disseminated intravascular coagulation and recalcitrant autoimmune hemolytic anemia. Three weeks before onset of illness, the patient received her first VARIVAX (Merck) (manufacturer unknown) (dose and route unknown), MMR (manufacturer unknown) (dose and route unknown) and hepatitis A (manufacturer unknown). There was no obvious contraindication to the administration of live virus vaccination. She had previously received all vaccinations as per the Advisory Committee on Immunization Practices (ACIP) recommended schedule, including the rotavirus series, which were well tolerated. Prior to death, vaccine strain varicella zoster virus (VZV) was detected in her cerebrospinal fluid (723 copies/mL), skin (137,156 copies/mL) and esophagus by PCR assays and immunohistochemistry staining, respectively. Throat swabs, also obtained prior to death, detected mumps and rubella by PCR assays. Stool samples submitted for viral electron microscopy were negative, including assessment for rotavirus. Ophthalmic examination revealed corneal dendrites with typical features of VZV infection. Autopsy demonstrated VZV dissemination in the lungs and liver as well as profound lymphoid depletion of lymph nodes and thymic tissue. VZV, mumps and rubella isolated from the patient were confined as vaccine genotypes Oka, Jeryl-Lynn and RA 27/3, respectively. The reporter considered the events to be related to VARIVAX (Merck)(manufacturer unknown), MMR (manufacturer unknown), methylprednisolone (manufacturer unknown) and hepatitis A (manufacturer unknown). Upon internal review, renal failure, hepatic failure and disseminated intravascular coagulation were considered to be medically significant. Additional information has been requested.


VAERS ID: 613449 (history)  
Form: Version 1.0  
Age:   
Sex: Male  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-12-07
Entered: 2015-12-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: TYLENOL; MOTRIN; SARA
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1512USA002586

Write-up: This spontaneous report was retrieved from a social network via Pfizer (assigned manufacturer control number: 2015420009) and was originally reported by the uncle of a male patient of unknown age. Information about the patient''s medical history and concurrent conditions was not provided. On an unknown date, the patient started therapy with TYLENOL and MOTRIN (for both therapies indication, dose, frequency, route of administration, lot number and expiration date were not provided). Subsequently, the patient was vaccinated with M-M-R II (dose, dose number, route of administration, lot number and expiration date were not provided). Other suspect therapies included SARA (indication, dose, frequency, route of administration, lot number and expiration date were not provided). Concomitant medication was not reported. According to the reporter, on an unknown date, SARA and M-M-R II "killed" his nephew. The reporter stated that he was life flighted to hospital and died. It was also reported that the patient was alive and flew to a county hospital and died. It was unknown if an autopsy was performed. The cause of death was also unknown. Additional information is not expected, since the reporter''s details were not provided.


Result pages: prev   16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=25&VAX[]=MEA&VAX[]=MER&VAX[]=MM&VAX[]=MMR&VAX[]=MMRV&VAXTYPES[]=Measles&DIED=Yes&VAX_YEAR_HIGH=2018&VAX_MONTH_HIGH=11


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166